Bio-Reference Laboratories, Inc. (NASDAQ:BRLI)

CAPS Rating: 3 out of 5

An independent clinical laboratory servicing the New York metropolitan area that offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases.

Recs

1
Player Avatar TMFBlacknGold (99.37) Submitted: 6/28/2012 11:02:08 PM : Underperform Start Price: $25.77 BRLI Score: +6.55

This came up in a screen for stocks with the highest gains in the last 4 weeks. With a fair book value of $7.28 this company is greatly overvalued. Profitable and an interesting business model, but only has $202 million in shareholders' equity as of 1Q12. Should be an easy red-thumb target.

Featured Broker Partners


Advertisement